Tikun Olam-Cannbit Pharmaceuticals Ltd

TASE:TKUN Stock Report

Market Cap: ₪27.7m

Tikun Olam-Cannbit Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 3/6

Tikun Olam-Cannbit Pharmaceuticals has a total shareholder equity of ₪5.9M and total debt of ₪12.8M, which brings its debt-to-equity ratio to 215.1%. Its total assets and total liabilities are ₪42.7M and ₪36.8M respectively.

Key information

215.1%

Debt to equity ratio

₪12.79m

Debt

Interest coverage ration/a
Cash₪4.18m
Equity₪5.94m
Total liabilities₪36.77m
Total assets₪42.71m

Recent financial health updates

Recent updates

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Jun 21
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 28
Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Jul 21
Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Oct 03
Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Jun 03
Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Oct 17
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

May 19
Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

Mar 19
Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 02
How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

Financial Position Analysis

Short Term Liabilities: TKUN's short term assets (₪15.4M) do not cover its short term liabilities (₪25.7M).

Long Term Liabilities: TKUN's short term assets (₪15.4M) exceed its long term liabilities (₪11.1M).


Debt to Equity History and Analysis

Debt Level: TKUN's net debt to equity ratio (144.9%) is considered high.

Reducing Debt: TKUN's debt to equity ratio has increased from 8.8% to 215.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable TKUN has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: TKUN is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 5% per year.


Discover healthy companies